ROMIPLOSTIM N01
Clinical trials for ROMIPLOSTIM N01 explained in plain language.
Never miss a new study
Get alerted when new ROMIPLOSTIM N01 trials appear
Sign up with your email to follow new studies for ROMIPLOSTIM N01, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Weekly injection could tame bleeding in kids with Hard-to-Treat ITP
Disease control Not yet recruitingThis study tests a drug called romiplostim, given as a weekly shot, in 100 children aged 1 to 18 with chronic immune thrombocytopenia (ITP) who haven't been helped by standard treatments. The goal is to see if it can safely raise platelet counts and reduce bleeding. Children will…
Matched conditions: ROMIPLOSTIM N01
Sponsor: Assiut University • Aim: Disease control
Last updated Jun 27, 2026 07:54 UTC
-
New drug aims to fix chemo side effect in breast cancer patients
Disease control Not yet recruitingThis study tests a drug called romiplostim N01 in 68 breast cancer patients whose platelet counts dropped too low due to chemotherapy. The goal is to see if weekly injections can bring platelet levels back up within two weeks, so patients can safely continue their cancer treatmen…
Matched conditions: ROMIPLOSTIM N01
Phase: NA • Sponsor: Tianjin Medical University Cancer Institute and Hospital • Aim: Disease control
Last updated Jun 26, 2026 14:36 UTC